The University of Iowa is taking steps toward creating a new institute devoted to developing cancer-fighting drugs. The institute, abbreviated as CANDID, would focus on accelerating new drug development from the lab to early clinical trials. Kevin Kregel, the UI’s executive vice president and provost, says it would be a partnership between the pharmacy school […]





